Article
Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk.
Molecular neurodegeneration - 21 Apr 2021
Novikova Gloriia, Andrews Shea J, Renton Alan E, Marcora Edoardo
Abstract excerpt
Alzheimer's disease (AD) is the most common type of dementia, affecting millions of people worldwide; however, no disease-modifying treatments are currently available. Genome-wide association studies (GWASs) have identified more than 40 loci associated with AD risk. However, most of the disease-associated variants reside in non-coding regions of the genome, making it difficult to elucidate how they affect disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
